Radioactive contamination
Some organs concentrate certain elements and hence radionuclide variants of those elements. This action may lead to much lower removal rates. For instance, the thyroid gland takes up a large percentage of any iodine that enters the body. Large quantities of inhaled or ingested radioactive iodine may impair or destroy the thyroid, while other tissues are affected to a lesser extent. Radioactive iodine-131 is a common fission product; it was a major component of the radioactivity released from the Chernobyl disaster, leading to nine fatal cases of pediatric thyroid cancer and hypothyroidism. On the other hand, radioactive iodine is used in the diagnosis and treatment of many diseases of the thyroid precisely because of the thyroid's selective uptake of iodine.
Isotopes of iodine
The gamma-emitting isotopes iodine-123 (half-life 13 hours), and (less commonly) the longer-lived and less energetic iodine-125 (half-life 59 days) are used as nuclear imaging tracers to evaluate the anatomic and physiologic function of the thyroid. Abnormal results may be caused by disorders such as Graves' disease or Hashimoto's thyroiditis. Both isotopes decay by electron capture (EC) to the corresponding tellurium nuclides, but in neither case are these the metastable nuclides Te-123m and Te125m (which are of higher energy, and are not produced from radioiodine). Instead, the excited tellurium nuclides decay immediately (half-life too short to detect). Following EC, the excited Te-123 from I-123 emits a high-speed 127 keV internal conversion electron (not a beta ray) about 13% of the time, but this does little cellular damage due to the nuclide's short half-life and the relatively small fraction of such events. In the remainder of cases, a 159 keV gamma ray is emitted, which is well-suited for gamma imaging.